Similarly, in prostate cancer, studies have shown that genes involved in oxidative stress response, such as SOD2 (superoxide dismutase 2) and CAT (catalase), play critical roles in determining the tumor’s response to radiotherapy [92, 93]. The gene discussed is CAT; the disease is neoplasm.